• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

165.35 -0.33 (-0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
24 25 Next >
News headline image
Is It Time to Buy the S&P 500's 3 Worst-Performing February Stocks? ↗
March 04, 2024
A handful of large-cap stocks are now on sale. The discount, however, doesn't necessarily make them worth buying. 
Via The Motley Fool
Topics Stocks
News headline image
Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit) ↗
February 29, 2024
Nvidia Corp. is one of the leading top stocks with 60% gain in 2024, but other lesser-known names have outperformed. 
Via Benzinga
News headline image
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday ↗
February 26, 2024
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak... 
Via Benzinga
Topics Stocks
News headline image
Analyst Scoreboard: 5 Ratings For Insulet ↗
February 23, 2024
 
Via Benzinga
News headline image
Insulet: Q4 Earnings Insights ↗
February 22, 2024
 
Via Benzinga
News headline image
Should you consider NASDAQ:PODD for growth investing? ↗
February 01, 2024
Exploring INSULET CORP (NASDAQ:PODD)'s growth characteristics. 
Via Chartmill
News headline image
DexCom: A Winner In Diabetes Management ↗
February 25, 2024
Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820... 
Via Talk Markets
News headline image
Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts ↗
February 23, 2024
After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday reflects edginess. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
February 22, 2024
 
Via Benzinga
News headline image
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
February 22, 2024
From Insulet Corporation
Via Business Wire
News headline image
INSULET CORP (NASDAQ:PODD) is a candidate for growth investors. Here's why. ↗
January 10, 2024
Exploring growth characteristics of INSULET CORP (NASDAQ:PODD). 
Via Chartmill
News headline image
Expert Ratings For Insulet ↗
December 21, 2023
 
Via Benzinga
News headline image
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum ↗
February 22, 2024
Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings. 
Via Benzinga
Topics Economy Stocks
News headline image
Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
February 13, 2024
From Insulet Corporation
Via Business Wire
News headline image
Should you consider NASDAQ:PODD for growth investing? ↗
December 19, 2023
Exploring growth characteristics of INSULET CORP (NASDAQ:PODD). 
Via Chartmill
News headline image
What 8 Analyst Ratings Have To Say About Insulet ↗
December 04, 2023
 
Via Benzinga
News headline image
Should you consider NASDAQ:PODD for growth investing? ↗
November 28, 2023
Why INSULET CORP (NASDAQ:PODD) qualifies as a high growth stock. 
Via Chartmill
News headline image
Earnings Scheduled For February 22, 2024 ↗
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
Via Benzinga
News headline image
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
February 07, 2024
From Insulet Corporation
Via Business Wire
News headline image
5 top healthcare stocks for earnings growth in 2024
January 25, 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
Via MarketBeat
News headline image
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs
January 22, 2024
With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs. 
Via MarketBeat
Topics Earnings
News headline image
Insulet Announces Changes to Board of Directors with Retirements and New Appointments
January 18, 2024
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
January 11, 2024
From Insulet Corporation
Via Business Wire
News headline image
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
January 08, 2024
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
News headline image
Top Stock Picks For Week Of December 25, 2023 ↗
December 27, 2023
MoneyLion Inc. is a data-driven, digital financial platform. Insulet Corporation is a leading developer, manufacturer, and marketer of the Omnipod Insulin Management System. 
Via Talk Markets
News headline image
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday ↗
December 21, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Insulet to Present at Upcoming Investor Conferences
November 28, 2023
From Insulet Corporation
Via Business Wire
Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029
November 17, 2023
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
November 15, 2023
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
November 10, 2023
 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap